GSR III Acquisition Corp Stock Price, News & Analysis

Terra Innovatum (to trade as NKLR) and GSR III Acquisition Corp. (Nasdaq: GSRT) announced GSRT shareholders approved the business combination on October 7, 2025. The transaction is expected to deliver $130 million of trust and equity financing at close to fund licensing, first-of-a-kind (FOAK) SOLO™ micro-modular reactor construction, and initial commercialization efforts. The combined company will be named Terra Innovatum Global N.V. and ordinary shares are expected to trade on Nasdaq under the ticker NKLR, subject to closing and listing conditions. Closing is expected in the coming days pending satisfaction or waiver of conditions.

Terra Innovatum, a micro-modular nuclear reactor developer, and GSR III Acquisition Corp. (NASDAQ: GSRT) have secured an additional $5 million PIPE commitment, bringing total equity financing to $42.5 million for their business combination. This includes $37 million in PIPE capital and $5.5 million from a bridge facility.

The funding will accelerate the deployment of their first-of-a-kind (FOAK) SOLO™ micro-modular reactor, with market deployment targeted for 2028. The company's approach focuses on a small reactor design using widely available components and fuel, avoiding the need for government subsidies. Following shareholder approval at the October 7, 2025 meeting, the combined company will trade on Nasdaq under the symbol "NKLR".

Terra Innovatum (NASDAQ:GSRT) announced accelerated plans to enter the medical radioisotope market with its SOLO™ micro-modular reactor. The company is developing partnerships with leading isotope producers like NorthStar, ANSTO, and BWXT Medical to expand global reach.

The global nuclear radioisotope market is projected to grow from $7 billion in 2025 to $11.68 billion by 2030. SOLO, expected to be commercially available by 2028, is designed as a precision isotope factory capable of producing multiple isotopes simultaneously, including Mo-99/Tc-99m, Iodine-131, Cobalt-60, Iridium-192, and Lutetium-177.

The microreactor aims to address current market challenges of centralized production, aging infrastructure, and supply chain vulnerabilities by enabling localized, on-demand isotope generation for hospitals and medical facilities worldwide.

Terra Innovatum (NASDAQ:GSRT) has signed a strategic MOU with RAIT 88, an Italian defense engineering center, to accelerate the global commercialization of their SOLO™ micro-modular nuclear reactors. The partnership focuses on deploying these reactors for both defense and civilian applications across NATO and allied nations.

The collaboration leverages RAIT 88's expertise in AI, robotics, and systems integration to enhance SOLO™ reactor deployment, operations, and training. The partnership is already facilitating commercial negotiations for projects potentially totaling over 1 GWe of capacity across Europe and Asia.

The agreement includes developing interactive training programs compliant with international nuclear regulatory standards and exploring virtual environments for maintenance and safety protocols assessment.

Terra Innovatum and GSR III Acquisition Corp. (NASDAQ:GSRT) are urging shareholders to vote in favor of their proposed business combination before the October 7, 2025 extraordinary general meeting. The vote deadline is set for October 6, 2025, at 11:59 p.m. ET.

Following the merger, the combined company will operate as Terra Innovatum and trade on Nasdaq under the symbol "NKLR". Terra Innovatum is developing the SOLO™ micro-modular nuclear reactor, targeting commercialization by 2028. The reactor features proliferation-resistant LEU fuel, inherent safety design, and factory-assembled modularity. The compact 35ft × 35ft footprint enables flexible deployment across various settings, from industrial hubs to urban areas.

Terra Innovatum (NASDAQ:GSRT) has signed a memorandum of understanding (MOU) with Ameresco (NYSE:AMRC) to establish a comprehensive framework for deploying SOLO™ micro-modular nuclear reactors. The partnership aims to deploy 50 SOLO™ reactor units across federal and commercial sites in the U.S.

The collaboration leverages Ameresco's national network and expertise for siting, development, construction, integration, operation, and decommissioning planning of the SOLO™ reactors. This strategic partnership represents a significant milestone in Terra Innovatum's path to commercialization, combining their innovative reactor technology with Ameresco's extensive experience in delivering advanced energy solutions.

Terra Innovatum and GSR III Acquisition Corp. (NASDAQ: GSRT) have secured a $37.5 million financing package for their upcoming business combination. The package includes a $32 million PIPE investment led by Segra Capital Management and a $5.5 million bridge facility. The funding will support the licensing and construction of Terra Innovatum's SOLO™ micro-modular nuclear reactor.

An extraordinary general meeting is scheduled for October 7, 2025, where GSRT shareholders will vote on the business combination. Following the merger's completion, the combined entity will operate as Terra Innovatum and trade on Nasdaq under the ticker symbol "NKLR".

Terra Innovatum (NASDAQ:GSRT) has achieved significant progress in the U.S. Nuclear Regulatory Commission (NRC) licensing process for its SOLO™ micro-modular reactor. The company has submitted multiple key regulatory documents in 2025, including commercial fuel use discussions, environmental reports, and Principal Design Criteria (PDC).

Key submissions include factory manufacturing protocols, core design presentations, and safety analysis reports. The company is utilizing commercially available low enriched uranium (LEU) fuel and implementing a factory-based deployment model to streamline approvals. Terra Innovatum aims to complete the NRC review of PDC and topical reports by end-2025, submit the Preliminary Safety Analysis Report in 2026, and achieve construction permit approval by 2027 with commercialization targeted for 2028.

Terra Innovatum (NASDAQ:GSRT) has signed a significant memorandum of understanding (MOU) with Conuar, a leading Argentinean nuclear systems manufacturer, to supply critical components for its SOLO micro-modular nuclear reactor. The partnership focuses on developing cooling, fuel components, and establishing a South American supply chain hub.

Under the agreement, Conuar will supply coolant tubes and plates, control rod mechanisms, fuel rods, and specialized alloy components. The collaboration leverages Conuar's 40+ years of nuclear expertise and positions Terra Innovatum to expand its presence in Latin America, a key growth region for nuclear energy.

The partnership aims to accelerate the deployment of clean, affordable, modular power while providing radioisotopes at scale, particularly targeting emerging markets with limited infrastructure through SOLO's off-grid capabilities.